Literature DB >> 25939891

[Local combination therapy of inflammatory dermatomycosis: A review of recommendations in national and international guidelines].

V A Czaika1, T Zuberbier.   

Abstract

BACKGROUND: Dermatomycosis, caused by fungi or dermatophytes is often accompanied by considerable inflammatory changes and is, therefore, of great clinical significance. Hence, it is reasonable to eliminate both the pathogen and all signs of inflammation by applying a drug combination of antimycotic and corticosteroid.
OBJECTIVES: How do national and international guidelines support this kind of therapy? Does consensus prevail, or are there a variety of recommendations?
MATERIALS AND METHODS: The present article uses the internationally recognized scientific search method to evaluate pharmaceuticals and discusses the results of the international recommendations.
RESULTS: The use of a corticosteroid/antimycotic combination therapy for the treatment of various types of inflammatory dermatomycosis is explicitly recommended by national and international guidelines. Although two significant German guidelines for treatment of dermatomycoses do not include usage of combination preparations, in view of their current relevance, however, their adaptation to international recommendations appears to make sense.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25939891     DOI: 10.1007/s00105-015-3597-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  23 in total

Review 1.  A review of the pathophysiology, prevention and treatment of irritant diaper dermatitis.

Authors:  David J Atherton
Journal:  Curr Med Res Opin       Date:  2004-05       Impact factor: 2.580

2.  Double-blind comparison of miconazole/corticosteroid combination versus miconazole in inflammatory dermatomycoses.

Authors:  S Nolting; K Rogalla
Journal:  Int J Dermatol       Date:  1995-02       Impact factor: 2.736

Review 3.  Topical therapy for dermatophytoses: should corticosteroids be included?

Authors:  Zulal Erbagci
Journal:  Am J Clin Dermatol       Date:  2004       Impact factor: 7.403

Review 4.  Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections.

Authors:  H L Greenberg; Tor A Shwayder; Nella Bieszk; David P Fivenson
Journal:  Pediatr Dermatol       Date:  2002 Jan-Feb       Impact factor: 1.588

5.  Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.

Authors:  Daisuke Kobayashi; Kei Kondo; Nobuyuki Uehara; Seiko Otokozawa; Naoki Tsuji; Atsuhito Yagihashi; Naoki Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 6.  Epidemiological trends in skin mycoses worldwide.

Authors:  Blanka Havlickova; Viktor A Czaika; Markus Friedrich
Journal:  Mycoses       Date:  2008-09       Impact factor: 4.377

Review 7.  Cutaneous fungal infections in the elderly.

Authors:  Daniel S Loo
Journal:  Dermatol Clin       Date:  2004-01       Impact factor: 3.478

Review 8.  Optimal management of fungal infections of the skin, hair, and nails.

Authors:  Aditya K Gupta; Elizabeth A Cooper; Jennifer E Ryder; Karyn A Nicol; Melody Chow; Maria M Chaudhry
Journal:  Am J Clin Dermatol       Date:  2004       Impact factor: 7.403

9.  [Dermatomycoses due to pets and farm animals : neglected infections?].

Authors:  P Nenoff; W Handrick; C Krüger; T Vissiennon; K Wichmann; Y Gräser; G Tchernev
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751

10.  Trichophyton mentagrophytes cause underestimated contagious zoophilic fungal infection.

Authors:  Viktor Alexander Czaika; Phi-Anh Lam
Journal:  Mycoses       Date:  2013-05       Impact factor: 4.377

View more
  3 in total

Review 1.  [Treatment of dermatoses : Significance and use of glucocorticoids in fixed combination with antifungals].

Authors:  P Mayser
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

2.  [Clotrimazole and ciclopirox olamine respectively in combination with methylprednisolone aceponate as extemporaneous formulations].

Authors:  J Wohlrab; R H H Neubert; E Sommer; J Michael
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

Review 3.  [Topical therapy of the scalp].

Authors:  J Wohlrab; J Michael
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.